Advertisement
Screener

BeyondSpring Inc. (BYSI) Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense

BeyondSpring Inc. Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense

BeyondSpring Inc. (BYSI) reported Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense of -$193.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.

Financial Statements › Expense Statement

us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense · last filed 2026-03-25

  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2019-03-31 was $0.00.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-06-30 was $0.00.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2018-03-31 was $0.00.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for the quarter ending 2017-12-31 was $0.00.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2025 was -$193.00K, a 301.04% decline from fiscal 2024.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2024 was $96.00K, a 81.64% decline from fiscal 2023.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2023 was $523.00K.
  • BeyondSpring Inc. unrecognized tax benefits, income tax penalties and interest expense for fiscal 2021 was $0.00.
Period endUnrecognized Tax Benefits, Income Tax Penalties and Interest Expense 3 monthUnrecognized Tax Benefits, Income Tax Penalties and Interest Expense 6 monthUnrecognized Tax Benefits, Income Tax Penalties and Interest Expense 9 monthUnrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 monthUnrecognized Tax Benefits, Income Tax Penalties and Interest Expense 12 month as first filed
2025-12-31-$193.00K
10-K · filed 2026-03-25
2024-12-31$96.00K
10-K · filed 2026-03-25
$525.00K
10-K · filed 2025-03-27
2023-12-31$523.00K
10-K · filed 2025-03-27
2022-12-31$315.00K
20-F · filed 2023-04-18
2021-12-31$0.00
10-K · filed 2026-03-25
2020-12-31$0.00
20-F · filed 2023-04-18
2019-12-31$0.00
20-F · filed 2022-04-14
2019-03-31$0.00
6-K · filed 2019-07-10
2018-12-31$203.00K
20-F · filed 2021-04-30
2018-06-30$0.00
6-K · filed 2018-10-23
$0.00
6-K · filed 2018-10-23
$0.00
derived: sum of 3 quarters · filed 2019-07-10
$0.00
derived: sum of 4 quarters · filed 2019-07-10
2018-03-31$0.00
6-K · filed 2019-07-10
$0.00
derived: sum of 2 quarters · filed 2019-07-10
$0.00
derived: sum of 3 quarters · filed 2019-07-10
$0.00
derived: sum of 4 quarters · filed 2019-07-10
2017-12-31$0.00
derived: 20-F 12 month − 6-K 9 month · filed 2018-04-03
$0.00
derived: sum of 2 quarters · filed 2018-04-03
$0.00
derived: sum of 3 quarters · filed 2018-10-23
$0.00
20-F · filed 2018-04-03
2017-09-30$0.00
6-K · filed 2017-11-09
$0.00
derived: sum of 2 quarters · filed 2018-10-23
$0.00
6-K · filed 2017-11-09
$0.00
derived: sum of 4 quarters · filed 2018-10-23
2017-06-30$0.00
6-K · filed 2018-10-23
$0.00
6-K · filed 2018-10-23
$0.00
derived: sum of 3 quarters · filed 2018-10-23
$0.00
derived: sum of 4 quarters · filed 2018-10-23
2017-03-31$0.00
6-K · filed 2018-06-21
$0.00
derived: sum of 2 quarters · filed 2018-06-21
$0.00
derived: sum of 3 quarters · filed 2018-06-21
$0.00
derived: sum of 4 quarters · filed 2018-06-21
2016-12-31$0.00
derived: 20-F 12 month − 6-K 9 month · filed 2018-04-03
$0.00
derived: sum of 2 quarters · filed 2018-04-03
$0.00
derived: sum of 3 quarters · filed 2018-04-03
$0.00
20-F · filed 2018-04-03
2016-09-30$0.00
6-K · filed 2017-11-09
$0.00
derived: sum of 2 quarters · filed 2017-11-09
$0.00
6-K · filed 2017-11-09
2016-06-30$0.00
derived: 6-K 6 month − 6-K 3 month · filed 2017-08-21
$0.00
6-K · filed 2017-08-21
2016-03-31$0.00
6-K · filed 2017-05-22
2015-12-31$0.00
20-F · filed 2017-04-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
NANOVIRICIDES, INC. (NNVC)United States$0.031B
CHINA PHARMA HOLDINGS, INC. (CPHI)$0.032B
Propanc Biopharma, Inc. (PPCB)$0.032B-0.13
IGC Pharma, Inc. (IGC)United States$0.029B-5.98
Hepion Pharmaceuticals, Inc. (HEPA)United States$0.029B-0.62
Transcode Therapeutics, Inc. (RNAZ)United States$0.029B-0.12
KYNTRA BIO, INC. (KYNB)United States$0.028B0.17
Context Therapeutics Inc. (CNTX)United States$0.034B-1.10
ROCKWELL MEDICAL, INC. (RMTI)United States$0.035B
MIRA PHARMACEUTICALS, INC. (MIRA)United States$0.036B-4.30